0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Immunoglobulin Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-17D3047
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Human Immunoglobulin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Immunoglobulin Market Research Report 2025

Code: QYRE-Auto-17D3047
Report
September 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Immunoglobulin Market

The global market for Human Immunoglobulin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Human Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human Immunoglobulin include Takeda, CSL, Grifols, Octapharma, Biotest, China National Pharmaceutical Group Corporation, CTBB, Hualan Bio, RASS, Shanxi Kangbao Biological Product, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Immunoglobulin.
The Human Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Immunoglobulin Market Report

Report Metric Details
Report Name Human Immunoglobulin Market
Segment by Type
  • Intramuscular Injection
  • Intravenous Injection
Segment by Application
  • Disease Prevention
  • Treatment
  • Diagnosis
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, CSL, Grifols, Octapharma, Biotest, China National Pharmaceutical Group Corporation, CTBB, Hualan Bio, RASS, Shanxi Kangbao Biological Product, Shuanglin Bio Pharma, Sichuan Yuanda Shuyang Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Human Immunoglobulin Market report?

Ans: The main players in the Human Immunoglobulin Market are Takeda, CSL, Grifols, Octapharma, Biotest, China National Pharmaceutical Group Corporation, CTBB, Hualan Bio, RASS, Shanxi Kangbao Biological Product, Shuanglin Bio Pharma, Sichuan Yuanda Shuyang Pharmaceutical

What are the Application segmentation covered in the Human Immunoglobulin Market report?

Ans: The Applications covered in the Human Immunoglobulin Market report are Disease Prevention, Treatment, Diagnosis, Other

What are the Type segmentation covered in the Human Immunoglobulin Market report?

Ans: The Types covered in the Human Immunoglobulin Market report are Intramuscular Injection, Intravenous Injection

1 Human Immunoglobulin Market Overview
1.1 Product Definition
1.2 Human Immunoglobulin by Type
1.2.1 Global Human Immunoglobulin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Intramuscular Injection
1.2.3 Intravenous Injection
1.3 Human Immunoglobulin by Application
1.3.1 Global Human Immunoglobulin Market Value by Application (2024 VS 2031)
1.3.2 Disease Prevention
1.3.3 Treatment
1.3.4 Diagnosis
1.3.5 Other
1.4 Global Human Immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Human Immunoglobulin Revenue 2020-2031
1.4.2 Global Human Immunoglobulin Sales 2020-2031
1.4.3 Global Human Immunoglobulin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Immunoglobulin Market Competition by Manufacturers
2.1 Global Human Immunoglobulin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Immunoglobulin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Immunoglobulin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Immunoglobulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Immunoglobulin, Product Type & Application
2.7 Global Key Manufacturers of Human Immunoglobulin, Date of Enter into This Industry
2.8 Global Human Immunoglobulin Market Competitive Situation and Trends
2.8.1 Global Human Immunoglobulin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Immunoglobulin Players Market Share by Revenue
2.8.3 Global Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Immunoglobulin Market Scenario by Region
3.1 Global Human Immunoglobulin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Immunoglobulin Sales by Region: 2020-2031
3.2.1 Global Human Immunoglobulin Sales by Region: 2020-2025
3.2.2 Global Human Immunoglobulin Sales by Region: 2026-2031
3.3 Global Human Immunoglobulin Revenue by Region: 2020-2031
3.3.1 Global Human Immunoglobulin Revenue by Region: 2020-2025
3.3.2 Global Human Immunoglobulin Revenue by Region: 2026-2031
3.4 North America Human Immunoglobulin Market Facts & Figures by Country
3.4.1 North America Human Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Immunoglobulin Sales by Country (2020-2031)
3.4.3 North America Human Immunoglobulin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Immunoglobulin Market Facts & Figures by Country
3.5.1 Europe Human Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Immunoglobulin Sales by Country (2020-2031)
3.5.3 Europe Human Immunoglobulin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Immunoglobulin Market Facts & Figures by Region
3.6.1 Asia Pacific Human Immunoglobulin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Immunoglobulin Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Immunoglobulin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Immunoglobulin Market Facts & Figures by Country
3.7.1 Latin America Human Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Immunoglobulin Sales by Country (2020-2031)
3.7.3 Latin America Human Immunoglobulin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Immunoglobulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Immunoglobulin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Immunoglobulin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Immunoglobulin Sales by Type (2020-2031)
4.1.1 Global Human Immunoglobulin Sales by Type (2020-2025)
4.1.2 Global Human Immunoglobulin Sales by Type (2026-2031)
4.1.3 Global Human Immunoglobulin Sales Market Share by Type (2020-2031)
4.2 Global Human Immunoglobulin Revenue by Type (2020-2031)
4.2.1 Global Human Immunoglobulin Revenue by Type (2020-2025)
4.2.2 Global Human Immunoglobulin Revenue by Type (2026-2031)
4.2.3 Global Human Immunoglobulin Revenue Market Share by Type (2020-2031)
4.3 Global Human Immunoglobulin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Immunoglobulin Sales by Application (2020-2031)
5.1.1 Global Human Immunoglobulin Sales by Application (2020-2025)
5.1.2 Global Human Immunoglobulin Sales by Application (2026-2031)
5.1.3 Global Human Immunoglobulin Sales Market Share by Application (2020-2031)
5.2 Global Human Immunoglobulin Revenue by Application (2020-2031)
5.2.1 Global Human Immunoglobulin Revenue by Application (2020-2025)
5.2.2 Global Human Immunoglobulin Revenue by Application (2026-2031)
5.2.3 Global Human Immunoglobulin Revenue Market Share by Application (2020-2031)
5.3 Global Human Immunoglobulin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Human Immunoglobulin Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Human Immunoglobulin Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Grifols Human Immunoglobulin Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Human Immunoglobulin Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Company Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biotest Human Immunoglobulin Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 China National Pharmaceutical Group Corporation
6.6.1 China National Pharmaceutical Group Corporation Company Information
6.6.2 China National Pharmaceutical Group Corporation Description and Business Overview
6.6.3 China National Pharmaceutical Group Corporation Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 China National Pharmaceutical Group Corporation Human Immunoglobulin Product Portfolio
6.6.5 China National Pharmaceutical Group Corporation Recent Developments/Updates
6.7 CTBB
6.7.1 CTBB Company Information
6.7.2 CTBB Description and Business Overview
6.7.3 CTBB Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CTBB Human Immunoglobulin Product Portfolio
6.7.5 CTBB Recent Developments/Updates
6.8 Hualan Bio
6.8.1 Hualan Bio Company Information
6.8.2 Hualan Bio Description and Business Overview
6.8.3 Hualan Bio Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hualan Bio Human Immunoglobulin Product Portfolio
6.8.5 Hualan Bio Recent Developments/Updates
6.9 RASS
6.9.1 RASS Company Information
6.9.2 RASS Description and Business Overview
6.9.3 RASS Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 RASS Human Immunoglobulin Product Portfolio
6.9.5 RASS Recent Developments/Updates
6.10 Shanxi Kangbao Biological Product
6.10.1 Shanxi Kangbao Biological Product Company Information
6.10.2 Shanxi Kangbao Biological Product Description and Business Overview
6.10.3 Shanxi Kangbao Biological Product Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shanxi Kangbao Biological Product Human Immunoglobulin Product Portfolio
6.10.5 Shanxi Kangbao Biological Product Recent Developments/Updates
6.11 Shuanglin Bio Pharma
6.11.1 Shuanglin Bio Pharma Company Information
6.11.2 Shuanglin Bio Pharma Description and Business Overview
6.11.3 Shuanglin Bio Pharma Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shuanglin Bio Pharma Human Immunoglobulin Product Portfolio
6.11.5 Shuanglin Bio Pharma Recent Developments/Updates
6.12 Sichuan Yuanda Shuyang Pharmaceutical
6.12.1 Sichuan Yuanda Shuyang Pharmaceutical Company Information
6.12.2 Sichuan Yuanda Shuyang Pharmaceutical Description and Business Overview
6.12.3 Sichuan Yuanda Shuyang Pharmaceutical Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sichuan Yuanda Shuyang Pharmaceutical Human Immunoglobulin Product Portfolio
6.12.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Immunoglobulin Industry Chain Analysis
7.2 Human Immunoglobulin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Immunoglobulin Production Mode & Process Analysis
7.4 Human Immunoglobulin Sales and Marketing
7.4.1 Human Immunoglobulin Sales Channels
7.4.2 Human Immunoglobulin Distributors
7.5 Human Immunoglobulin Customer Analysis
8 Human Immunoglobulin Market Dynamics
8.1 Human Immunoglobulin Industry Trends
8.2 Human Immunoglobulin Market Drivers
8.3 Human Immunoglobulin Market Challenges
8.4 Human Immunoglobulin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Human Immunoglobulin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Immunoglobulin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Immunoglobulin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Immunoglobulin Sales (KG) of Key Manufacturers (2020-2025)
 Table 5. Global Human Immunoglobulin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Immunoglobulin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Immunoglobulin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Immunoglobulin Average Price (USD/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Immunoglobulin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Immunoglobulin, Product Type & Application
 Table 12. Global Key Manufacturers of Human Immunoglobulin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunoglobulin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Immunoglobulin Sales by Region (2020-2025) & (KG)
 Table 18. Global Human Immunoglobulin Sales Market Share by Region (2020-2025)
 Table 19. Global Human Immunoglobulin Sales by Region (2026-2031) & (KG)
 Table 20. Global Human Immunoglobulin Sales Market Share by Region (2026-2031)
 Table 21. Global Human Immunoglobulin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Immunoglobulin Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Immunoglobulin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Immunoglobulin Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Immunoglobulin Sales by Country (2020-2025) & (KG)
 Table 27. North America Human Immunoglobulin Sales by Country (2026-2031) & (KG)
 Table 28. North America Human Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Immunoglobulin Sales by Country (2020-2025) & (KG)
 Table 32. Europe Human Immunoglobulin Sales by Country (2026-2031) & (KG)
 Table 33. Europe Human Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Immunoglobulin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Immunoglobulin Sales by Region (2020-2025) & (KG)
 Table 37. Asia Pacific Human Immunoglobulin Sales by Region (2026-2031) & (KG)
 Table 38. Asia Pacific Human Immunoglobulin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Immunoglobulin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Immunoglobulin Sales by Country (2020-2025) & (KG)
 Table 42. Latin America Human Immunoglobulin Sales by Country (2026-2031) & (KG)
 Table 43. Latin America Human Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Immunoglobulin Sales by Country (2020-2025) & (KG)
 Table 47. Middle East and Africa Human Immunoglobulin Sales by Country (2026-2031) & (KG)
 Table 48. Middle East and Africa Human Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Immunoglobulin Sales (KG) by Type (2020-2025)
 Table 51. Global Human Immunoglobulin Sales (KG) by Type (2026-2031)
 Table 52. Global Human Immunoglobulin Sales Market Share by Type (2020-2025)
 Table 53. Global Human Immunoglobulin Sales Market Share by Type (2026-2031)
 Table 54. Global Human Immunoglobulin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Immunoglobulin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Immunoglobulin Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Immunoglobulin Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Immunoglobulin Price (USD/Kg) by Type (2020-2025)
 Table 59. Global Human Immunoglobulin Price (USD/Kg) by Type (2026-2031)
 Table 60. Global Human Immunoglobulin Sales (KG) by Application (2020-2025)
 Table 61. Global Human Immunoglobulin Sales (KG) by Application (2026-2031)
 Table 62. Global Human Immunoglobulin Sales Market Share by Application (2020-2025)
 Table 63. Global Human Immunoglobulin Sales Market Share by Application (2026-2031)
 Table 64. Global Human Immunoglobulin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Immunoglobulin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Immunoglobulin Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Immunoglobulin Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Immunoglobulin Price (USD/Kg) by Application (2020-2025)
 Table 69. Global Human Immunoglobulin Price (USD/Kg) by Application (2026-2031)
 Table 70. Takeda Company Information
 Table 71. Takeda Description and Business Overview
 Table 72. Takeda Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 73. Takeda Human Immunoglobulin Product
 Table 74. Takeda Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 78. CSL Human Immunoglobulin Product
 Table 79. CSL Recent Developments/Updates
 Table 80. Grifols Company Information
 Table 81. Grifols Description and Business Overview
 Table 82. Grifols Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 83. Grifols Human Immunoglobulin Product
 Table 84. Grifols Recent Developments/Updates
 Table 85. Octapharma Company Information
 Table 86. Octapharma Description and Business Overview
 Table 87. Octapharma Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 88. Octapharma Human Immunoglobulin Product
 Table 89. Octapharma Recent Developments/Updates
 Table 90. Biotest Company Information
 Table 91. Biotest Description and Business Overview
 Table 92. Biotest Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 93. Biotest Human Immunoglobulin Product
 Table 94. Biotest Recent Developments/Updates
 Table 95. China National Pharmaceutical Group Corporation Company Information
 Table 96. China National Pharmaceutical Group Corporation Description and Business Overview
 Table 97. China National Pharmaceutical Group Corporation Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 98. China National Pharmaceutical Group Corporation Human Immunoglobulin Product
 Table 99. China National Pharmaceutical Group Corporation Recent Developments/Updates
 Table 100. CTBB Company Information
 Table 101. CTBB Description and Business Overview
 Table 102. CTBB Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 103. CTBB Human Immunoglobulin Product
 Table 104. CTBB Recent Developments/Updates
 Table 105. Hualan Bio Company Information
 Table 106. Hualan Bio Description and Business Overview
 Table 107. Hualan Bio Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 108. Hualan Bio Human Immunoglobulin Product
 Table 109. Hualan Bio Recent Developments/Updates
 Table 110. RASS Company Information
 Table 111. RASS Description and Business Overview
 Table 112. RASS Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 113. RASS Human Immunoglobulin Product
 Table 114. RASS Recent Developments/Updates
 Table 115. Shanxi Kangbao Biological Product Company Information
 Table 116. Shanxi Kangbao Biological Product Description and Business Overview
 Table 117. Shanxi Kangbao Biological Product Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 118. Shanxi Kangbao Biological Product Human Immunoglobulin Product
 Table 119. Shanxi Kangbao Biological Product Recent Developments/Updates
 Table 120. Shuanglin Bio Pharma Company Information
 Table 121. Shuanglin Bio Pharma Description and Business Overview
 Table 122. Shuanglin Bio Pharma Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 123. Shuanglin Bio Pharma Human Immunoglobulin Product
 Table 124. Shuanglin Bio Pharma Recent Developments/Updates
 Table 125. Sichuan Yuanda Shuyang Pharmaceutical Company Information
 Table 126. Sichuan Yuanda Shuyang Pharmaceutical Description and Business Overview
 Table 127. Sichuan Yuanda Shuyang Pharmaceutical Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 128. Sichuan Yuanda Shuyang Pharmaceutical Human Immunoglobulin Product
 Table 129. Sichuan Yuanda Shuyang Pharmaceutical Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Human Immunoglobulin Distributors List
 Table 133. Human Immunoglobulin Customers List
 Table 134. Human Immunoglobulin Market Trends
 Table 135. Human Immunoglobulin Market Drivers
 Table 136. Human Immunoglobulin Market Challenges
 Table 137. Human Immunoglobulin Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Immunoglobulin
 Figure 2. Global Human Immunoglobulin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Immunoglobulin Market Share by Type: 2024 & 2031
 Figure 4. Intramuscular Injection Product Picture
 Figure 5. Intravenous Injection Product Picture
 Figure 6. Global Human Immunoglobulin Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Human Immunoglobulin Market Share by Application: 2024 & 2031
 Figure 8. Disease Prevention
 Figure 9. Treatment
 Figure 10. Diagnosis
 Figure 11. Other
 Figure 12. Global Human Immunoglobulin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Human Immunoglobulin Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Human Immunoglobulin Sales (2020-2031) & (KG)
 Figure 15. Global Human Immunoglobulin Average Price (USD/Kg) & (2020-2031)
 Figure 16. Human Immunoglobulin Report Years Considered
 Figure 17. Human Immunoglobulin Sales Share by Manufacturers in 2024
 Figure 18. Global Human Immunoglobulin Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Human Immunoglobulin Players: Market Share by Revenue in Human Immunoglobulin in 2024
 Figure 20. Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Human Immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Human Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 23. North America Human Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Human Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 27. Europe Human Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Human Immunoglobulin Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Human Immunoglobulin Revenue Market Share by Region (2020-2031)
 Figure 35. China Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Human Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Human Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Human Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Human Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Human Immunoglobulin by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Human Immunoglobulin by Type (2020-2031)
 Figure 57. Global Human Immunoglobulin Price (USD/Kg) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Human Immunoglobulin by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Human Immunoglobulin by Application (2020-2031)
 Figure 60. Global Human Immunoglobulin Price (USD/Kg) by Application (2020-2031)
 Figure 61. Human Immunoglobulin Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona